accession stringclasses 716
values | cik stringclasses 420
values | company stringclasses 422
values | ticker stringclasses 394
values | filed_date stringdate 2026-07-21 00:00:00 2026-10-19 00:00:00 ⌀ | form stringclasses 1
value | signal stringclasses 12
values | negative bool 2
classes | file_name stringclasses 691
values | url stringlengths 44 98 |
|---|---|---|---|---|---|---|---|---|---|
0001193125-26-403481 | 1468748 | Kodiak Sciences Inc. | KOD | 2026-09-28 | 8-K | endpoint_met | false | d185059dex991.htm | https://www.sec.gov/Archives/edgar/data/1468748/000119312526403481/d185059dex991.htm |
0002007919-26-000050 | 2007919 | Inhibrx Biosciences, Inc. | INBX | 2026-09-28 | 8-K | topline | false | inhibrxpresentation_sept.htm | https://www.sec.gov/Archives/edgar/data/2007919/000200791926000050/inhibrxpresentation_sept.htm |
0002007919-26-000050 | 2007919 | Inhibrx Biosciences, Inc. | INBX | 2026-09-28 | 8-K | breakthrough | false | inhibrxpresentation_sept.htm | https://www.sec.gov/Archives/edgar/data/2007919/000200791926000050/inhibrxpresentation_sept.htm |
0001818382-26-000011 | 1818382 | Humacyte, Inc. | HUMA | 2026-09-28 | 8-K | fast_track | false | huma-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1818382/000181838226000011/huma-ex99_1.htm |
0001213900-26-104099 | 1907223 | Greenland Mines Ltd | null | 2026-09-28 | 8-K | clinical_hold | true | ea030675101ex10-1.htm | https://www.sec.gov/Archives/edgar/data/1907223/000121390026104099/ea030675101ex10-1.htm |
0001628280-26-063740 | 1736730 | Camp4 Therapeutics Corp | CAMP | 2026-09-28 | 8-K | topline | false | camp-20260928.htm | https://www.sec.gov/Archives/edgar/data/1736730/000162828026063740/camp-20260928.htm |
0001493152-26-044605 | 1701478 | Azitra, Inc. | AZTR | 2026-09-28 | 8-K | clinical_hold | true | ex1-1.htm | https://www.sec.gov/Archives/edgar/data/1701478/000149315226044605/ex1-1.htm |
0001493152-26-044605 | 1701478 | Azitra, Inc. | AZTR | 2026-09-28 | 8-K | ind | false | ex1-1.htm | https://www.sec.gov/Archives/edgar/data/1701478/000149315226044605/ex1-1.htm |
0001720580-26-000060 | 1720580 | Adicet Bio, Inc. | ACET | 2026-09-28 | 8-K | fast_track | false | acet-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1720580/000172058026000060/acet-ex99_1.htm |
0001720580-26-000060 | 1720580 | Adicet Bio, Inc. | ACET | 2026-09-28 | 8-K | ind | false | acet-ex99_2.htm | https://www.sec.gov/Archives/edgar/data/1720580/000172058026000060/acet-ex99_2.htm |
0001628280-26-063510 | 1411685 | Vistagen Therapeutics, Inc. | VTGN | 2026-09-25 | 8-K | endpoint_met | false | vistagenseptember2026cor.htm | https://www.sec.gov/Archives/edgar/data/1411685/000162828026063510/vistagenseptember2026cor.htm |
0001398733-26-000048 | 1398733 | Aquestive Therapeutics, Inc. | AQST | 2026-09-25 | 8-K | crl | true | corporatepresentation-se.htm | https://www.sec.gov/Archives/edgar/data/1398733/000139873326000048/corporatepresentation-se.htm |
0001628280-26-063316 | 1411685 | Vistagen Therapeutics, Inc. | VTGN | 2026-09-24 | 8-K | endpoint_missed | true | ex99120260924.htm | https://www.sec.gov/Archives/edgar/data/1411685/000162828026063316/ex99120260924.htm |
0001104659-26-110412 | 1509261 | Rezolute, Inc. | RZLT | 2026-09-24 | 8-K | topline | false | tm2625842d1_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1509261/000110465926110412/tm2625842d1_ex99-1.htm |
0001104659-26-110412 | 1509261 | Rezolute, Inc. | RZLT | 2026-09-24 | 8-K | endpoint_missed | true | tm2625842d1_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1509261/000110465926110412/tm2625842d1_ex99-1.htm |
0001193125-26-400062 | 1994702 | Kyverna Therapeutics, Inc. | KYTX | 2026-09-24 | 8-K | topline | false | kytx-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1994702/000119312526400062/kytx-ex99_1.htm |
0001493152-26-044182 | 1506983 | Glucotrack, Inc. | GCTK | 2026-09-24 | 8-K | clinical_hold | true | ex10-1.htm | https://www.sec.gov/Archives/edgar/data/1506983/000149315226044182/ex10-1.htm |
0001193125-26-401157 | 1070494 | ACADIA PHARMACEUTICALS INC | ACAD | 2026-09-24 | 8-K | topline | false | d168737dex991.htm | https://www.sec.gov/Archives/edgar/data/1070494/000119312526401157/d168737dex991.htm |
0001193125-26-399383 | 1937653 | Zymeworks Inc. | ZYME | 2026-09-23 | 8-K | orphan | false | d270232dex102.htm | https://www.sec.gov/Archives/edgar/data/1937653/000119312526399383/d270232dex102.htm |
0001193125-26-399383 | 1937653 | Zymeworks Inc. | ZYME | 2026-09-23 | 8-K | ind | false | d270232dex102.htm | https://www.sec.gov/Archives/edgar/data/1937653/000119312526399383/d270232dex102.htm |
0001683168-26-007340 | 1534525 | Xenetic Biosciences, Inc. | XBIO | 2026-09-23 | 8-K | interim | false | xenetic_ex9901.htm | https://www.sec.gov/Archives/edgar/data/1534525/000168316826007340/xenetic_ex9901.htm |
0001213900-26-102611 | 1721484 | Longeveron Inc. | LGVN | 2026-09-23 | 8-K | topline | false | ea030614701ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1721484/000121390026102611/ea030614701ex99-1.htm |
0001213900-26-102611 | 1721484 | Longeveron Inc. | LGVN | 2026-09-23 | 8-K | endpoint_missed | true | ea030614701ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1721484/000121390026102611/ea030614701ex99-1.htm |
0001213900-26-102611 | 1721484 | Longeveron Inc. | LGVN | 2026-09-23 | 8-K | fast_track | false | ea030614701ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1721484/000121390026102611/ea030614701ex99-1.htm |
0001213900-26-102611 | 1721484 | Longeveron Inc. | LGVN | 2026-09-23 | 8-K | orphan | false | ea030614701ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1721484/000121390026102611/ea030614701ex99-1.htm |
0001140361-26-037371 | 874015 | IONIS PHARMACEUTICALS INC | IONS | 2026-09-23 | 8-K | endpoint_met | false | ef20082626_8k.htm | https://www.sec.gov/Archives/edgar/data/874015/000114036126037371/ef20082626_8k.htm |
0001140361-26-037371 | 874015 | IONIS PHARMACEUTICALS INC | IONS | 2026-09-23 | 8-K | interim | false | ef20082626_8k.htm | https://www.sec.gov/Archives/edgar/data/874015/000114036126037371/ef20082626_8k.htm |
0001213900-26-102691 | 1907223 | Greenland Mines Ltd | null | 2026-09-23 | 8-K | clinical_hold | true | ea030640801ex10-1.htm | https://www.sec.gov/Archives/edgar/data/1907223/000121390026102691/ea030640801ex10-1.htm |
0001193125-26-399378 | 2044725 | Evommune, Inc. | EVMN | 2026-09-23 | 8-K | topline | false | evmn-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/2044725/000119312526399378/evmn-ex99_1.htm |
0001104659-26-109809 | 921114 | Armata Pharmaceuticals, Inc. | ARMP | 2026-09-23 | 8-K | breakthrough | false | tm2625977d1_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/921114/000110465926109809/tm2625977d1_ex99-1.htm |
0001104659-26-109809 | 921114 | Armata Pharmaceuticals, Inc. | ARMP | 2026-09-23 | 8-K | fast_track | false | tm2625977d1_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/921114/000110465926109809/tm2625977d1_ex99-1.htm |
0001193805-26-001277 | 1768224 | Arcturus Therapeutics Holdings Inc. | ARCT | 2026-09-23 | 8-K | fast_track | false | e665798_ex99-2.htm | https://www.sec.gov/Archives/edgar/data/1768224/000119380526001277/e665798_ex99-2.htm |
0001193805-26-001277 | 1768224 | Arcturus Therapeutics Holdings Inc. | ARCT | 2026-09-23 | 8-K | orphan | false | e665798_ex99-2.htm | https://www.sec.gov/Archives/edgar/data/1768224/000119380526001277/e665798_ex99-2.htm |
0001628280-26-063046 | 1411685 | Vistagen Therapeutics, Inc. | VTGN | 2026-09-22 | 8-K | topline | false | ex99120260922.htm | https://www.sec.gov/Archives/edgar/data/1411685/000162828026063046/ex99120260922.htm |
0001193125-26-397219 | 1607678 | Viking Therapeutics, Inc. | VKTX | 2026-09-22 | 8-K | topline | false | vktx-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1607678/000119312526397219/vktx-ex99_1.htm |
0000730263-26-000028 | 730263 | THOR INDUSTRIES INC | THO | 2026-09-22 | 8-K | topline | false | thoq4fy26-investorpresen.htm | https://www.sec.gov/Archives/edgar/data/730263/000073026326000028/thoq4fy26-investorpresen.htm |
0001178253-26-000035 | 1178253 | SCYNEXIS INC | SCYX | 2026-09-22 | 8-K | orphan | false | scyx-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1178253/000117825326000035/scyx-ex99_1.htm |
0001104659-26-109639 | 1671502 | Quoin Pharmaceuticals Ltd. | QNRX | 2026-09-22 | 8-K | fast_track | false | tm2625948d1_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1671502/000110465926109639/tm2625948d1_ex99-1.htm |
0001104659-26-109639 | 1671502 | Quoin Pharmaceuticals Ltd. | QNRX | 2026-09-22 | 8-K | orphan | false | tm2625948d1_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1671502/000110465926109639/tm2625948d1_ex99-1.htm |
0001193125-26-397221 | 1907108 | Lexeo Therapeutics, Inc. | LXEO | 2026-09-22 | 8-K | topline | false | lxeo-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1907108/000119312526397221/lxeo-ex99_1.htm |
0001193125-26-397221 | 1907108 | Lexeo Therapeutics, Inc. | LXEO | 2026-09-22 | 8-K | ind | false | lxeo-ex2_1.htm | https://www.sec.gov/Archives/edgar/data/1907108/000119312526397221/lxeo-ex2_1.htm |
0001171843-26-006161 | 1069530 | FILANA THERAPEUTICS, INC. | FLNA | 2026-09-22 | 8-K | clinical_hold | true | f8k_092226.htm | https://www.sec.gov/Archives/edgar/data/1069530/000117184326006161/f8k_092226.htm |
0001171843-26-006162 | 1738021 | Compass Therapeutics, Inc. | CMPX | 2026-09-22 | 8-K | orphan | false | exh_991.htm | https://www.sec.gov/Archives/edgar/data/1738021/000117184326006162/exh_991.htm |
0001104659-26-109465 | 744218 | Celldex Therapeutics, Inc. | CLDX | 2026-09-22 | 8-K | topline | false | tm2625892d1_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/744218/000110465926109465/tm2625892d1_ex99-1.htm |
0001104659-26-109465 | 744218 | Celldex Therapeutics, Inc. | CLDX | 2026-09-22 | 8-K | endpoint_met | false | tm2625892d1_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/744218/000110465926109465/tm2625892d1_ex99-1.htm |
0001493152-26-043724 | 1855485 | Calidi Biotherapeutics, Inc. | null | 2026-09-22 | 8-K | clinical_hold | true | ex10-1.htm | https://www.sec.gov/Archives/edgar/data/1855485/000149315226043724/ex10-1.htm |
0001193125-26-397870 | 1840439 | Biomea Fusion, Inc. | BMEA | 2026-09-22 | 8-K | topline | false | bmea-20260922.htm | https://www.sec.gov/Archives/edgar/data/1840439/000119312526397870/bmea-20260922.htm |
0001193125-26-397996 | 1107421 | Alaunos Therapeutics, Inc. | TCRT | 2026-09-22 | 8-K | clinical_hold | true | tcrt-ex10_1.htm | https://www.sec.gov/Archives/edgar/data/1107421/000119312526397996/tcrt-ex10_1.htm |
0001140361-26-037234 | 1472091 | PDS Biotechnology Corp | PDSB | 2026-09-21 | 8-K | interim | false | ef20082538_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1472091/000114036126037234/ef20082538_ex99-1.htm |
0001140361-26-037234 | 1472091 | PDS Biotechnology Corp | PDSB | 2026-09-21 | 8-K | fast_track | false | ef20082538_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1472091/000114036126037234/ef20082538_ex99-1.htm |
0001193125-26-396094 | 1645460 | Cue Biopharma, Inc. | CUE | 2026-09-21 | 8-K | topline | false | d21238d8k.htm | https://www.sec.gov/Archives/edgar/data/1645460/000119312526396094/d21238d8k.htm |
0001193125-26-396094 | 1645460 | Cue Biopharma, Inc. | CUE | 2026-09-21 | 8-K | ind | false | d21238dex991.htm | https://www.sec.gov/Archives/edgar/data/1645460/000119312526396094/d21238dex991.htm |
0001193125-26-396065 | 1520262 | Alkermes plc. | ALKS | 2026-09-21 | 8-K | topline | false | alks-20260921.htm | https://www.sec.gov/Archives/edgar/data/1520262/000119312526396065/alks-20260921.htm |
0001193125-26-396690 | 1370053 | ANAPTYSBIO, INC | ANAB | 2026-09-21 | 8-K | pdufa | false | anab-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1370053/000119312526396690/anab-ex99_1.htm |
0001193125-26-395031 | 1839970 | BlossomHill Therapeutics, Inc. | BLSM | 2026-09-18 | 8-K | fast_track | false | d266261dex991.htm | https://www.sec.gov/Archives/edgar/data/1839970/000119312526395031/d266261dex991.htm |
0001193125-26-395031 | 1839970 | BlossomHill Therapeutics, Inc. | BLSM | 2026-09-18 | 8-K | orphan | false | d266261dex991.htm | https://www.sec.gov/Archives/edgar/data/1839970/000119312526395031/d266261dex991.htm |
0001193125-26-395694 | 1488039 | ATOSSA THERAPEUTICS, INC. | ATOS | 2026-09-18 | 8-K | topline | false | atos-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1488039/000119312526395694/atos-ex99_1.htm |
0001193125-26-395694 | 1488039 | ATOSSA THERAPEUTICS, INC. | ATOS | 2026-09-18 | 8-K | orphan | false | atos-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1488039/000119312526395694/atos-ex99_1.htm |
0001193125-26-395694 | 1488039 | ATOSSA THERAPEUTICS, INC. | ATOS | 2026-09-18 | 8-K | ind | false | atos-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1488039/000119312526395694/atos-ex99_1.htm |
0001193125-26-394492 | 1544227 | Tempest Therapeutics, Inc. | TPST | 2026-09-17 | 8-K | ind | false | d185404dex101.htm | https://www.sec.gov/Archives/edgar/data/1544227/000119312526394492/d185404dex101.htm |
0001493152-26-043053 | 1971532 | Telomir Pharmaceuticals, Inc. | TELO | 2026-09-17 | 8-K | ind | false | form8-k.htm | https://www.sec.gov/Archives/edgar/data/1971532/000149315226043053/form8-k.htm |
0001829126-26-010156 | 1979414 | NEONC TECHNOLOGIES HOLDINGS, INC. | NTHI | 2026-09-17 | 8-K | endpoint_met | false | neonctechnologies_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1979414/000182912626010156/neonctechnologies_ex99-1.htm |
0001140361-26-036866 | 320017 | LISATA THERAPEUTICS, INC. | LSTA | 2026-09-17 | 8-K | topline | false | ef20082158_ex99-2.htm | https://www.sec.gov/Archives/edgar/data/320017/000114036126036866/ef20082158_ex99-2.htm |
0001140361-26-036866 | 320017 | LISATA THERAPEUTICS, INC. | LSTA | 2026-09-17 | 8-K | clinical_hold | true | ef20082158_ex10-2.htm | https://www.sec.gov/Archives/edgar/data/320017/000114036126036866/ef20082158_ex10-2.htm |
0001104659-26-108565 | 1211583 | FENNEC PHARMACEUTICALS INC. | FENC | 2026-09-17 | 8-K | endpoint_met | false | fencf-20260917x8k.htm | https://www.sec.gov/Archives/edgar/data/1211583/000110465926108565/fencf-20260917x8k.htm |
0001398733-26-000044 | 1398733 | Aquestive Therapeutics, Inc. | AQST | 2026-09-17 | 8-K | crl | true | ndapressrelease-9x14x202.htm | https://www.sec.gov/Archives/edgar/data/1398733/000139873326000044/ndapressrelease-9x14x202.htm |
0001683168-26-007206 | 882291 | AETHLON MEDICAL INC | AEMD | 2026-09-17 | 8-K | topline | false | aethlon_ex9902.htm | https://www.sec.gov/Archives/edgar/data/882291/000168316826007206/aethlon_ex9902.htm |
0001683168-26-007206 | 882291 | AETHLON MEDICAL INC | AEMD | 2026-09-17 | 8-K | clinical_hold | true | aethlon_ex0201.htm | https://www.sec.gov/Archives/edgar/data/882291/000168316826007206/aethlon_ex0201.htm |
0001683168-26-007181 | 1534525 | Xenetic Biosciences, Inc. | XBIO | 2026-09-16 | 8-K | interim | false | xenetic_ex9902.htm | https://www.sec.gov/Archives/edgar/data/1534525/000168316826007181/xenetic_ex9902.htm |
0001437749-26-030492 | 1719406 | NRX Pharmaceuticals, Inc. | NRXP | 2026-09-16 | 8-K | breakthrough | false | ex_1016862.htm | https://www.sec.gov/Archives/edgar/data/1719406/000143774926030492/ex_1016862.htm |
0001437749-26-030492 | 1719406 | NRX Pharmaceuticals, Inc. | NRXP | 2026-09-16 | 8-K | fast_track | false | ex_1016862.htm | https://www.sec.gov/Archives/edgar/data/1719406/000143774926030492/ex_1016862.htm |
0001628280-26-062137 | 1576885 | Acumen Pharmaceuticals, Inc. | ABOS | 2026-09-16 | 8-K | topline | false | finalinvestordayslides_9.htm | https://www.sec.gov/Archives/edgar/data/1576885/000162828026062137/finalinvestordayslides_9.htm |
0001193125-26-391280 | 1831828 | Vera Therapeutics, Inc. | VERA | 2026-09-15 | 8-K | topline | false | d32300dex991.htm | https://www.sec.gov/Archives/edgar/data/1831828/000119312526391280/d32300dex991.htm |
0001193125-26-391280 | 1831828 | Vera Therapeutics, Inc. | VERA | 2026-09-15 | 8-K | interim | false | d32300dex992.htm | https://www.sec.gov/Archives/edgar/data/1831828/000119312526391280/d32300dex992.htm |
0001193125-26-391903 | 1544227 | Tempest Therapeutics, Inc. | TPST | 2026-09-15 | 8-K | clinical_hold | true | d108044dex101.htm | https://www.sec.gov/Archives/edgar/data/1544227/000119312526391903/d108044dex101.htm |
0001599298-26-000081 | 1599298 | Summit Therapeutics Inc. | SMMT | 2026-09-15 | 8-K | interim | false | a2026_prx0915xharmoniltf.htm | https://www.sec.gov/Archives/edgar/data/1599298/000159929826000081/a2026_prx0915xharmoniltf.htm |
0001599298-26-000081 | 1599298 | Summit Therapeutics Inc. | SMMT | 2026-09-15 | 8-K | pdufa | false | a2026_prx0915xharmoniltf.htm | https://www.sec.gov/Archives/edgar/data/1599298/000159929826000081/a2026_prx0915xharmoniltf.htm |
0001193125-26-391358 | 1691082 | LB PHARMACEUTICALS INC | LBRX | 2026-09-15 | 8-K | topline | false | d157620dex991.htm | https://www.sec.gov/Archives/edgar/data/1691082/000119312526391358/d157620dex991.htm |
0001493152-26-042672 | 109657 | GT Biopharma, Inc. | GTBP | 2026-09-15 | 8-K | clinical_hold | true | ex10-1.htm | https://www.sec.gov/Archives/edgar/data/109657/000149315226042672/ex10-1.htm |
0001193125-26-391390 | 2044725 | Evommune, Inc. | EVMN | 2026-09-15 | 8-K | topline | false | evmn-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/2044725/000119312526391390/evmn-ex99_1.htm |
0001193125-26-391378 | 1835022 | Coya Therapeutics, Inc. | COYA | 2026-09-15 | 8-K | topline | false | d896544d8k.htm | https://www.sec.gov/Archives/edgar/data/1835022/000119312526391378/d896544d8k.htm |
0001193125-26-391378 | 1835022 | Coya Therapeutics, Inc. | COYA | 2026-09-15 | 8-K | fast_track | false | d896544d8k.htm | https://www.sec.gov/Archives/edgar/data/1835022/000119312526391378/d896544d8k.htm |
0001835268-26-000034 | 1835268 | Connect Biopharma Holdings Ltd | CNTB | 2026-09-15 | 8-K | topline | false | exhibit991.htm | https://www.sec.gov/Archives/edgar/data/1835268/000183526826000034/exhibit991.htm |
0001835268-26-000034 | 1835268 | Connect Biopharma Holdings Ltd | CNTB | 2026-09-15 | 8-K | interim | false | cntb-20260915.htm | https://www.sec.gov/Archives/edgar/data/1835268/000183526826000034/cntb-20260915.htm |
0001193125-26-391328 | 1839970 | BlossomHill Therapeutics, Inc. | BLSM | 2026-09-15 | 8-K | fast_track | false | d168153dex991.htm | https://www.sec.gov/Archives/edgar/data/1839970/000119312526391328/d168153dex991.htm |
0001193125-26-391328 | 1839970 | BlossomHill Therapeutics, Inc. | BLSM | 2026-09-15 | 8-K | orphan | false | d168153dex991.htm | https://www.sec.gov/Archives/edgar/data/1839970/000119312526391328/d168153dex991.htm |
0001628280-26-061973 | 1048477 | BIOMARIN PHARMACEUTICAL INC | BMRN | 2026-09-15 | 8-K | discontinue | true | bmrn-20260915.htm | https://www.sec.gov/Archives/edgar/data/1048477/000162828026061973/bmrn-20260915.htm |
0001104659-26-107485 | 1566044 | Yarrow Bioscience, Inc. | YARW | 2026-09-14 | 8-K | clinical_hold | true | tm2624918d3_ex1-1.htm | https://www.sec.gov/Archives/edgar/data/1566044/000110465926107485/tm2624918d3_ex1-1.htm |
0001493152-26-042483 | 1971532 | Telomir Pharmaceuticals, Inc. | TELO | 2026-09-14 | 8-K | ind | false | form8-k.htm | https://www.sec.gov/Archives/edgar/data/1971532/000149315226042483/form8-k.htm |
0001599298-26-000078 | 1599298 | Summit Therapeutics Inc. | SMMT | 2026-09-14 | 8-K | interim | false | a2026_prx0913xharmoni-2o.htm | https://www.sec.gov/Archives/edgar/data/1599298/000159929826000078/a2026_prx0913xharmoni-2o.htm |
0001599298-26-000078 | 1599298 | Summit Therapeutics Inc. | SMMT | 2026-09-14 | 8-K | pdufa | false | a2026_prx0913xharmoni-2o.htm | https://www.sec.gov/Archives/edgar/data/1599298/000159929826000078/a2026_prx0913xharmoni-2o.htm |
0001193125-26-390577 | 2036042 | Sionna Therapeutics, Inc. | SION | 2026-09-14 | 8-K | topline | false | d148638dex991.htm | https://www.sec.gov/Archives/edgar/data/2036042/000119312526390577/d148638dex991.htm |
0001104659-26-107273 | 1727196 | Scholar Rock Holding Corp | SRRK | 2026-09-14 | 8-K | endpoint_met | false | tm2625362d1_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1727196/000110465926107273/tm2625362d1_ex99-1.htm |
0001193125-26-389836 | 1661998 | Q32 Bio Inc. | QTTB | 2026-09-14 | 8-K | topline | false | d158730dex991.htm | https://www.sec.gov/Archives/edgar/data/1661998/000119312526389836/d158730dex991.htm |
0001493152-26-042466 | 1535955 | Lipocine Inc. | LPCN | 2026-09-14 | 8-K | endpoint_missed | true | ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1535955/000149315226042466/ex99-1.htm |
0001213900-26-099700 | 1711754 | Inmune Bio, Inc. | INMB | 2026-09-14 | 8-K | fast_track | false | ea030540401ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1711754/000121390026099700/ea030540401ex99-1.htm |
0001671927-26-000026 | 1671927 | Immunocore Holdings plc | IMCR | 2026-09-14 | 8-K | topline | false | pressrelease-tebexamenroll.htm | https://www.sec.gov/Archives/edgar/data/1671927/000167192726000026/pressrelease-tebexamenroll.htm |
0001437749-26-030244 | 1563665 | Harvard Apparatus Regenerative Technology, Inc. | HRGN | 2026-09-14 | 8-K | clinical_hold | true | ex_1015499.htm | https://www.sec.gov/Archives/edgar/data/1563665/000143774926030244/ex_1015499.htm |
0001104659-26-107275 | 1813814 | Definium Therapeutics, Inc. | DFTX | 2026-09-14 | 8-K | topline | false | tm2625365d1_ex99-2.htm | https://www.sec.gov/Archives/edgar/data/1813814/000110465926107275/tm2625365d1_ex99-2.htm |
0001104659-26-107275 | 1813814 | Definium Therapeutics, Inc. | DFTX | 2026-09-14 | 8-K | endpoint_met | false | tm2625365d1_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1813814/000110465926107275/tm2625365d1_ex99-1.htm |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.